Creation of a metabolic monitoring program for second-generation (atypical) antipsychotics.

Second-generation or ''atypical'' antipsychotics can cause metabolic derangements that lead to diabetes and cardiovascular disease. To potentially minimize these adverse effects, the University of Medicine and Dentistry of New Jersey - University Correctional HealthCare (UCHC) and the New Jersey Department of Corrections (NJ DOC) created a metabolic monitoring program that was incorporated into the electronic medical record. This program is used statewide by UCHC psychiatrists working within the NJ DOC.